Originally Published in IP Frontline | November 12, 2015
With 2016 approaching, Chief IP and Patent Counsel will convene for Consero’s IP Forum for Pharmaceuticals & Biotechnology to examine the lessons learned from the most significant judicial decisions of 2015. The Forum, hosted by Consero, an international leader in developing high-level, invitation-only events for senior executives, will be held December 6-8 at the Biltmore Miami Coral Gables in Miami, Florida.
“In this time of changing patent law, pharmaceutical and biotechnology executives’ IP strategies must be flexible, aggressive, and fully attuned to the latest developments from the courts,” said Paul Mandell, Founder & CEO of Consero. “Consero’s 2015 IP Forum for Pharmaceuticals & Biotechnology will provide an opportunity for Chief IP and Chief Patent Counsel to review key court cases of 2015, as well as share best practices and strategies that will help them to lead their departments and companies in the right direction in the year ahead.”
“The Forum will review the implications of 2015’s key rulings that impact companies’ global IP portfolios,” said Jessica Druckman, Founder & SVP of Program Development at Consero. “We will explore top-of-mind issues, including what upcoming cases Chief IP and Patent Counsel should be aware of, and how those cases can potentially affect overall IP strategy.”
Additional topics will include: